BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31339174)

  • 1. Rate or Rhythm Control in Older Atrial Fibrillation Patients: Risk of Fall-Related Injuries and Syncope.
    Dalgaard F; Pallisgaard JL; Numé AK; Lindhardt TB; Gislason GH; Torp-Pedersen C; Ruwald MH
    J Am Geriatr Soc; 2019 Oct; 67(10):2023-2030. PubMed ID: 31339174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate and rhythm therapy in patients with atrial fibrillation and the risk of pacing and bradyarrhythmia.
    Dalgaard F; Pallisgaard JL; Lindhardt TB; Torp-Pedersen C; Gislason GH; Ruwald MH
    Heart Rhythm; 2019 Sep; 16(9):1348-1356. PubMed ID: 31125673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs.
    Hagengaard L; Søgaard P; Espersen M; Sessa M; Lund PE; Krogager ML; Torp-Pedersen C; Kragholm KH; Polcwiartek C
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):137-144. PubMed ID: 31263883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
    Bosch NA; Rucci JM; Massaro JM; Winter MR; Quinn EK; Chon KH; McManus DD; Walkey AJ
    Chest; 2021 Apr; 159(4):1452-1459. PubMed ID: 33619010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study.
    Walkey AJ; Evans SR; Winter MR; Benjamin EJ
    Chest; 2016 Jan; 149(1):74-83. PubMed ID: 26270396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of atrial fibrillation: current therapeutic strategies.
    Lévy S
    Am Heart J; 2001 Feb; 141(2 Suppl):S15-21. PubMed ID: 11174354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drug therapy among patients presenting to emergency department with symptomatic atrial fibrillation - a prospective nationwide cohort.
    Penttilä T; Mäkynen H; Hartikainen J; Hyppölä H; Lauri T; Lehto M; Lund J; Raatikainen MJP;
    Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):81. PubMed ID: 28810904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic use from 1991 to 2007: insights from the Canadian Registry of Atrial Fibrillation (CARAF I and II).
    Andrade JG; Connolly SJ; Dorian P; Green M; Humphries KH; Klein GJ; Sheldon R; Talajic M; Kerr CR
    Heart Rhythm; 2010 Sep; 7(9):1171-7. PubMed ID: 20430112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Kipp R; Askari M; Fan J; Field ME; Turakhia MP
    JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.
    Olshansky B; Rosenfeld LE; Warner AL; Solomon AJ; O'Neill G; Sharma A; Platia E; Feld GK; Akiyama T; Brodsky MA; Greene HL;
    J Am Coll Cardiol; 2004 Apr; 43(7):1201-8. PubMed ID: 15063430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
    Friberg L
    Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Antiarrhythmic Drug Therapy With Syncope and Pacemaker Implantation in Patients With Atrial Fibrillation.
    Kim YG; Lee HS; Kim H; Kim M; Jeong JH; Choi YY; Shim J; Choi JI; Kim YH
    J Am Coll Cardiol; 2024 Mar; 83(11):1027-1038. PubMed ID: 38479951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockers.
    Hansen ML; Gadsbøll N; Gislason GH; Abildstrom SZ; Schramm TK; Folke F; Friberg J; Sørensen R; Rasmussen S; Poulsen HE; Køber L; Madsen M; Torp-Pedersen C
    Europace; 2008 Apr; 10(4):395-402. PubMed ID: 18258807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
    Corley SD; Epstein AE; DiMarco JP; Domanski MJ; Geller N; Greene HL; Josephson RA; Kellen JC; Klein RC; Krahn AD; Mickel M; Mitchell LB; Nelson JD; Rosenberg Y; Schron E; Shemanski L; Waldo AL; Wyse DG;
    Circulation; 2004 Mar; 109(12):1509-13. PubMed ID: 15007003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of post-discharge fall-related injuries among adult patients with syncope: A nationwide cohort study.
    Numé AK; Carlson N; Gerds TA; Holm E; Pallisgaard J; Søndergaard KB; Hansen ML; Vinther M; Hansen J; Gislason G; Torp-Pedersen C; Ruwald MH
    PLoS One; 2018; 13(11):e0206936. PubMed ID: 30462687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.
    Allen Lapointe NM; Sun JL; Kaplan S; d'Almada P; Al-Khatib SM
    Am J Cardiol; 2008 Apr; 101(8):1134-41. PubMed ID: 18394447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.
    Ornelas-Loredo A; Kany S; Abraham V; Alzahrani Z; Darbar FA; Sridhar A; Ahmed M; Alamar I; Menon A; Zhang M; Chen Y; Hong L; Konda S; Darbar D
    JAMA Cardiol; 2020 Jan; 5(1):57-64. PubMed ID: 31774463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.